Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1Phase 2/3 1

Status

Completed 33Terminated 5Unknown 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 5

Sponsor

Cancer Type

Classical hematology 5Thoracic 1Other hematologic neoplasm 1Myeloid 1Genitourinary 1

Conditions

Neoplasms 5Anemia 5Prostatic Neoplasms 1Pleural Effusion, Malignant 1Pleural Effusion 1Lung Neoplasms 1Fatigue 1Critical Illness 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1

Interventions

Cyclophosphamide 17fludarabine phosphate 14Whole-Body Irradiation 11Mycophenolic Acid 9Epoetin Alfa 9Cyclosporine 9Busulfan 9fludarabine 8Cord Blood Stem Cell Transplantation 8Antilymphocyte Serum 8Filgrastim 6Tacrolimus 5Radiotherapy 5Peripheral Blood Stem Cell Transplantation 5Methotrexate 5Darbepoetin alfa 5Dalteparin 5Cytarabine 5eltrombopag 4Tinzaparin 4Thiotepa 4Platelet Transfusion 4Melphalan 4Etoposide 4Arsenic Trioxide 4thymoglobulin 3epoetin beta 3Vorinostat 3Transplantation 3Methylprednisolone 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Terminated × Darbepoetin alfa × Classical hematology × Clear all
NCT00858364 2022-11-30

Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy

Amgen

Phase 3 Terminated
2,549 enrolled 19 charts
Classical hematologyThoracic

Anemia, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Pleural Effusion, Pleural Effusion, Malignant

NCT00381836 2015-12-04

Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced Hormone Independent Prostate Cancer

University of Aarhus

Phase 2/3 Terminated
140 enrolled
Classical hematologyGenitourinary

Anemia, Fatigue, Neoplasms, Prostatic Neoplasms, Critical Illness

NCT00989092 2014-01-29

Darbepoetin Alfa and Anemia of Cancer

Amgen

Phase 2 Terminated
287 enrolled 21 charts
Classical hematology

Anemia, Carcinoma, Neoplasms

NCT00386152 2013-07-19

A Study Comparing Two Different PROCRIT Doses to a Dose of ARANESP in Anemic Cancer Patients Receiving Chemotherapy

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Phase 2 Terminated
235 enrolled 13 charts
Classical hematology

Anemia, Neoplasms

NCT00210002 2006-11-14

Evaluation of Iron Supplementation During Darbepoetin Alfa Treatment in Prophylaxis of Severe Anaemia Chemo-Induced

Institut Claudius Regaud

Phase 2 Terminated
55 enrolled
Classical hematology

Anemia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡